These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22641268)

  • 1. Synthesis of selective inhibitors against V. cholerae sialidase and human cytosolic sialidase NEU2.
    Khedri Z; Li Y; Cao H; Qu J; Yu H; Muthana MM; Chen X
    Org Biomol Chem; 2012 Aug; 10(30):6112-20. PubMed ID: 22641268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triazole-linked transition state analogs as selective inhibitors against V. cholerae sialidase.
    Slack TJ; Li W; Shi D; McArthur JB; Zhao G; Li Y; Xiao A; Khedri Z; Yu H; Liu Y; Chen X
    Bioorg Med Chem; 2018 Nov; 26(21):5751-5757. PubMed ID: 30389408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying selective inhibitors against the human cytosolic sialidase NEU2 by substrate specificity studies.
    Li Y; Cao H; Yu H; Chen Y; Lau K; Qu J; Thon V; Sugiarto G; Chen X
    Mol Biosyst; 2011 Apr; 7(4):1060-72. PubMed ID: 21206954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NEU1-selective sialidase inhibitor, C9-butyl-amide-DANA, blocks sialidase activity and NEU1-mediated bioactivities in human lung in vitro and murine lung in vivo.
    Hyun SW; Liu A; Liu Z; Cross AS; Verceles AC; Magesh S; Kommagalla Y; Kona C; Ando H; Luzina IG; Atamas SP; Piepenbrink KH; Sundberg EJ; Guang W; Ishida H; Lillehoj EP; Goldblum SE
    Glycobiology; 2016 Aug; 26(8):834-49. PubMed ID: 27226251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: selective inhibitors of lysosomal sialidase (NEU1).
    Magesh S; Moriya S; Suzuki T; Miyagi T; Ishida H; Kiso M
    Bioorg Med Chem Lett; 2008 Jan; 18(2):532-7. PubMed ID: 18068975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of the human cytosolic sialidase Neu2. Evidence for the dynamic nature of substrate recognition.
    Chavas LM; Tringali C; Fusi P; Venerando B; Tettamanti G; Kato R; Monti E; Wakatsuki S
    J Biol Chem; 2005 Jan; 280(1):469-75. PubMed ID: 15501818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of delta4-beta-D-glucopyranosiduronic acids as mimetics of 2,3-unsaturated sialic acids for sialidase inhibition.
    Florio P; Thomson RJ; Alafaci A; Abo S; von Itzstein M
    Bioorg Med Chem Lett; 1999 Jul; 9(14):2065-8. PubMed ID: 10450982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoenzymatic Syntheses of Sialylated Oligosaccharides Containing C5-Modified Neuraminic Acids for Dual Inhibition of Hemagglutinins and Neuraminidases.
    Birikaki L; Pradeau S; Armand S; Priem B; Márquez-Domínguez L; Reyes-Leyva J; Santos-López G; Samain E; Driguez H; Fort S
    Chemistry; 2015 Jul; 21(30):10903-12. PubMed ID: 26088695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 9-Azido-9-deoxy-2,3-difluorosialic Acid as a Subnanomolar Inhibitor against Bacterial Sialidases.
    Li W; Santra A; Yu H; Slack TJ; Muthana MM; Shi D; Liu Y; Chen X
    J Org Chem; 2019 Jun; 84(11):6697-6708. PubMed ID: 31083938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoenzymatic synthesis of sialosides containing C7-modified sialic acids and their application in sialidase substrate specificity studies.
    Khedri Z; Li Y; Muthana S; Muthana MM; Hsiao CW; Yu H; Chen X
    Carbohydr Res; 2014 May; 389():100-11. PubMed ID: 24680514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of neuraminidase with neuraminic acid C-glycosides.
    Wang Q; Wolff M; Polat T; Du Y; Linhardt RJ
    Bioorg Med Chem Lett; 2000 May; 10(9):941-4. PubMed ID: 10853664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complexity in influenza virus targeted drug design: interaction with human sialidases.
    Chavas LM; Kato R; Suzuki N; von Itzstein M; Mann MC; Thomson RJ; Dyason JC; McKimm-Breschkin J; Fusi P; Tringali C; Venerando B; Tettamanti G; Monti E; Wakatsuki S
    J Med Chem; 2010 Apr; 53(7):2998-3002. PubMed ID: 20222714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homology modeling of human sialidase enzymes NEU1, NEU3 and NEU4 based on the crystal structure of NEU2: hints for the design of selective NEU3 inhibitors.
    Magesh S; Suzuki T; Miyagi T; Ishida H; Kiso M
    J Mol Graph Model; 2006 Oct; 25(2):196-207. PubMed ID: 16427342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saturation transfer difference (STD) 1H-NMR experiments and in silico docking experiments to probe the binding of N-acetylneuraminic acid and derivatives to Vibrio cholerae sialidase.
    Haselhorst T; Wilson JC; Thomson RJ; McAtamney S; Menting JG; Coppel RL; von Itzstein M
    Proteins; 2004 Aug; 56(2):346-53. PubMed ID: 15211517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of selective inhibitors for human neuraminidase isoenzymes using C4,C7-modified 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA) analogues.
    Zhang Y; Albohy A; Zou Y; Smutova V; Pshezhetsky AV; Cairo CW
    J Med Chem; 2013 Apr; 56(7):2948-58. PubMed ID: 23530623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects and specificity of synthetic sialyldendrimers toward recombinant human cytosolic sialidase 2 (NEU2).
    Rahman MM; Kitao S; Tsuji D; Suzuki K; Sakamoto J; Matsuoka K; Matsuzawa F; Aikawa S; Itoh K
    Glycobiology; 2013 Apr; 23(4):495-504. PubMed ID: 23363739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of novel 3-C-alkylated-Neu5Ac2en derivatives as probes of influenza virus sialidase 150-loop flexibility.
    Rudrawar S; Kerry PS; Rameix-Welti MA; Maggioni A; Dyason JC; Rose FJ; van der Werf S; Thomson RJ; Naffakh N; Russell RJ; von Itzstein M
    Org Biomol Chem; 2012 Nov; 10(43):8628-39. PubMed ID: 22976385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular insight into substrate recognition by human cytosolic sialidase NEU2.
    Mozzi A; Mazzacuva P; Zampella G; Forcella ME; Fusi PA; Monti E
    Proteins; 2012 Apr; 80(4):1123-32. PubMed ID: 22228546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple synthesis of N-perfluoroacylated and N-acylated glycals of neuraminic acid with a cyclic aminic substituent at the 4α position as possible inhibitors of sialidases.
    Rota P; Allevi P; Agnolin IS; Mattina R; Papini N; Anastasia M
    Org Biomol Chem; 2012 Apr; 10(14):2885-94. PubMed ID: 22395901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Streptococcus pneumoniae NanC: STRUCTURAL INSIGHTS INTO THE SPECIFICITY AND MECHANISM OF A SIALIDASE THAT PRODUCES A SIALIDASE INHIBITOR.
    Owen CD; Lukacik P; Potter JA; Sleator O; Taylor GL; Walsh MA
    J Biol Chem; 2015 Nov; 290(46):27736-48. PubMed ID: 26370075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.